Actively Recruiting
Prospective Multicenter Study Evaluating Performance and Stability of the SMS Femoral Stem in Total Hip Arthroplasty
Led by Medacta International SA · Updated on 2026-10-08
260
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the performance and stability of the SMS femoral stem used in total hip arthroplasty for patients with hip conditions such as dysplasia, osteoarthritis, traumatic arthritis, or avascular necrosis of the femoral head. The study is prospective, multicenter, open, and observational without randomization or control groups. It focuses on long-term outcomes over a 10-year period after implantation. Participants will undergo total hip replacement surgery using the Medacta SMS femoral stem. The study will follow these patients to assess how well the implant performs and remains stable over time. The evaluation includes clinical performance, hip function, quality of life, safety regarding adverse events, and fixation stability, all monitored from enrollment through 10 years post-treatment. During the study, participants will have regular assessments to monitor implant survival and hip function, along with evaluations of their overall quality of life and any safety concerns related to the device. Researchers will collect data on adverse events and implant fixation. The total participation duration spans up to 10 years, allowing for long-term observation of treatment outcomes and implant durability.
CONDITIONS
Brief Title
Multicentre SMS Study - FR
Research Team
P
Paul Maisongrosse
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here